It is unclear whether the selling stakeholders include Practo's early backers, a list that includes now-defunct startup accelerator, The Morpheus, or its employees loo king to vest their stock options.

The Gurgaon-based company, which was valued at $500 million post the closure of its last round of funding in October 2017, has earmarked about $100 million towards the new venture, according to a senior executive of the firm.

The idea is to diversify and offer more to customers. Such experimentation is gaining ground among ehealth players, who are venturing into new territories such as insurance and private label medicines by making use of data like never before.